Erratum to: Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis (Nature Medicine, (2018), 24, 7, (986-993), 10.1038/s41591-018-0078-7);Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis

Nature Medicine

Volumn 24, Issue 7, 2018, Pages 986-993

  Savas, Peter ^a   Virassamy, Balaji ^a   Ye, Chengzhong ^a,b,c   Salim, Agus ^b,d   Mintoff, Christopher P ^a   Caramia, Franco ^a   Salgado, Roberto ^a,e   Byrne, David J ^f   Teo, Zhi L ^a   Dushyanthen, Sathana ^a   Byrne, Ann ^a   Wein, Lironne ^a   Luen, Stephen J ^a   Poliness, Catherine ^f   Nightingale, Sophie S ^f   Skandarajah, Anita S ^f,g   Gyorki, David E ^f   Thornton, Chantel M ^f   Beavis, Paul A ^a   Fox, Stephen B ^a,f   Darcy, Phillip K ^a   Speed, Terence P ^a,b   MacKay, Laura K ^a   Neeson, Paul J ^a   Loi, Sherene ^a   more..

^a UNIVERSITY OF MELBOURNE   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c Tsinghua University   (China)

^d LA TROBE UNIVERSITY   (Australia)

^e Department of Anesthesiology and Pain Management   (Belgium)

^f PETER MACCALLUM CANCER CENTRE   (Australia)

^g ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CANCER SURVIVAL; CD8+ T LYMPHOCYTE; CELL HETEROGENEITY; CELL ISOLATION; HUMAN; HUMAN CELL; IMMUNOSURVEILLANCE; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; RNA SEQUENCE; SINGLE CELL ANALYSIS; T LYMPHOCYTE SUBPOPULATION; TRIPLE NEGATIVE BREAST CANCER; TUMOR ASSOCIATED LEUKOCYTE; BREAST TUMOR; DISEASE FREE SURVIVAL; FEMALE; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; KAPLAN MEIER METHOD; METABOLISM; PATHOLOGY; PROCEDURES; PROGNOSIS; SEQUENCE ANALYSIS;

CD3 ANTIGEN; CD8 ANTIGEN;

BREAST NEOPLASMS; CD3 COMPLEX; CD8 ANTIGENS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOLOGIC MEMORY; KAPLAN-MEIER ESTIMATE; LYMPHOCYTES, TUMOR-INFILTRATING; PROGNOSIS; SEQUENCE ANALYSIS, RNA; SINGLE-CELL ANALYSIS; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 85049055113     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/s41591-018-0176-6     Document Type: Erratum

References (57)

1. Savas, P. et al. Clinical relevance of host immunity in breast cancer: from TILs to the clinic. Nat. Rev. Clin. Oncol. 13, 228-241 (2016).
2. Ruffell, B. et al. Leukocyte composition of human breast cancer. Proc. Natl Acad. Sci. USA 109, 2796-2801 (2012).
3. Adams, S. et al. Phase 2 study of pembrolizumab (pembro) monotherapy for previously treated metastatic triple-negative breast cancer (mTNBC): KEYNOTE-086 cohort A. J. Clin. Oncol. 35 no. 15-suppl, 1008 (2017).
4. Schmid, P. et al. Atezolizumab in metastatic TNBC (mTNBC): long-term clinical outcomes and biomarker analyses. Cancer Res. 77, 2986 (2017).
5. Loi, S. et al. Relationship between tumor infiltrating lymphocyte (TIL) levels and response to pembrolizumab (pembro) in metastatic triple-negative breast cancer (mTNBC): results from KEYNOTE-086. Ann. Oncol. 28, LBA13 (2017).
6. Loi, S.et al. Pooled individual patient data analysis of stromal tumor infiltrating lymphocytes in primary triple negative breast cancer treated with anthracycline-based chemotherapy. Cancer Res. 76, abstr. S1-03 (2015).
7. Nolan, E. et al. Combined immune checkpoint blockade as a therapeutic strategy for BRCA1-mutated breast cancer. Sci. Transl. Med. 9, eaal4922 (2017).
8. + follicular helper T cell infiltration predicts breast cancer survival. J. Clin. Invest. 123, 2873-2892 (2013).
9. Plitas, G. et al. Regulatory T cells exhibit distinct features in human breast cancer. Immunity 45, 1122-1134 (2016).
10. + lung-resident memory T cells. Nat. Immunol. 17, 1467-1478 (2016).
11. Kumar, B. V. et al. Human tissue-resident memory t cells are defined by core transcriptional and functional signatures in lymphoid and mucosal sites. Cell Reports 20, 2921-2934 (2017).
12. Mackay, L. K. et al. The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin. Nat. Immunol. 14, 1294-1301 (2016).
13. Schenkel, J. M. & Masopust, D. Tissue-resident memory T cells. Immunity 41, 886-897 (2014).
14. Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381-386 (2014).
15. Mueller, S. N. & Mackay, L. K. Tissue-resident memory T cells: local specialists in immune defence. Nat. Rev. Immunol. 16, 79-89 (2016).
16. Malik, B. T. et al. Resident memory T cells in the skin mediate durable immunity to melanoma. Sci. Immunol. 2, eaam6346 (2017).
17. Nizard, M. et al. Induction of resident memory T cells enhances the efficacy of cancer vaccine. Nat. Commun. 8, 15221 (2017).
18. Ganesan, A. P. et al. Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer. Nat. Immunol. 18, 940-950 (2017).
19. Thompson, E. D., Enriquez, H. L., Fu, Y. X. & Engelhard, V. H. Tumor masses support naive T cell infiltration, activation, and differentiation into effectors. J. Exp. Med. 207, 1791-1804 (2010).
20. Riaz, N. et al. Tumor and microenvironment evolution during immunotherapy with nivolumab. Cell 171, 934-949.e915 (2017).
21. Tumeh, P. C. et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 515, 568-571 (2014).
22. Desmedt, C. et al. Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes. Clinical Cancer Res. 14, 5158-5165 (2008).
23. Teschendorff, A. E., Miremadi, A., Pinder, S. E., Ellis, I. O. & Caldas, C. An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer. Genome Biol. 8, R157 (2007).
24. Denkert, C. et al. Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. J. Clin. Oncol. 28, 105-113 (2010).
25. Loi, S. et al. Tumor infiltrating lymphocytes (TILs) indicate trastuzumab benefit in early-stage HER2-positive breast cancer (HER2+ BC). Cancer Res. 73, abstr. S1-05 (2013).
26. Loi, S. et al. Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial. Ann. Oncol. 25, 1544-1550 (2014).
27. Luen, S. J. et al. Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study. Lancet Oncol. 18, 52-62 (2017).
28. Salgado, R. et al. Tumor-infiltrating lymphocytes and associations with pathological complete response and event-free survival in HER2-positive early-stage breast cancer treated with lapatinib and trastuzumab: a secondary analysis of the NeoALTTO trial. JAMA Oncol 1, 448-454 (2015).
29. + T-cell infiltration and breast cancer survival in 12,439 patients. Ann. Oncol 25, 1536-1543 (2014).
30. DeNardo, D. G. & Coussens, L. M. Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. BCR 9, 212 (2007).
31. Topalian, S. L., Muul, L. M., Solomon, D. & Rosenberg, S. A. Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials. J. Immunol. Methods 102, 127-141 (1987).
32. Stack, E. C., Wang, C., Roman, K. A. & Hoyt, C. C. Multiplexed immunohistochemistry, imaging, and quantitation: a review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis. Methods 70, 46-58 (2014).
33. Jiang, H., Lei, R., Ding, S. W. & Zhu, S. Skewer: a fast and accurate adapter trimmer for next-generation sequencing paired-end reads. BMC Bioinformatics 15, 182 (2014).
34. Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 34, 525-527 (2016).
35. Soneson, C., Love, M. I. & Robinson, M. D. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Res 4, 1521 (2015).
36. Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
37. Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014).
38. Liu, R. et al. Why weight? Modelling sample and observational level variability improves power in RNA-seq analyses. Nucleic Acids Res. 43, e97 (2015).
39. Bolotin, D. A. et al. MiXCR: software for comprehensive adaptive immunity profiling. Nat. Methods 12, 380-381 (2015).
40. Bolotin, D. A. et al. Antigen receptor repertoire profiling from RNA-seq data. Nat. Biotechnol. 35, 908-911 (2017).
41. Macosko, E. Z. et al. Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell 161, 1202-1214 (2015).
42. Risso, D., Perraudeau, F., Gribkova, S., Dudoit, S. & Vert, J.-P. ZINB-WaVE: a general and flexible method for signal extraction from single-cell RNA-seq data. Preprint at https://doi.org/10.1101/125112 (2017).
43. Huang, M. et al. SAVER: Gene expression recovery for UMI-based single cell RNA sequencing. Preprint at https://doi.org/10.1101/138677 (2017).
44. Ye, C., Speed, T.P. & Salim, A. DECENT: differential expression with capture efficiency adjustment for single-cell RNA-seq data. Preprint at https://doi.org/10.1101/225177 (2017).
45. Wu, D. & Smyth, G. K. Camera: a competitive gene set test accounting for inter-gene correlation. Nucleic Acids Res. 40, e133 (2012).
46. Scialdone, A. et al. Computational assignment of cell-cycle stage from single-cell transcriptome data. Methods 85, 54-61 (2015).
47. Lun, A. T., McCarthy, D. J. & Marioni, J. C. A step-by-step workflow for low-level analysis of single-cell RNA-seq data with Bioconductor. F1000Res 5, 2122 (2016).
48. Qiu, X. et al. Reversed graph embedding resolves complex single-cell trajectories. Nat. Methods 14, 979-982 (2017).
49. Curtis, C. et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486, 346-352 (2012).
50. Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1 (2013).
51. Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747-752 (2000).
52. McCarthy, D. J., Chen, Y. & Smyth, G. K. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res 40, 4288-4297 (2012).
53. Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139-140 (2010).
54. Smyth, G. K., Michaud, J. & Scott, H. S. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 21, 2067-2075 (2005).
55. Wu, D. et al. ROAST: rotation gene set tests for complex microarray experiments. Bioinformatics 26, 2176-2182 (2010).
56. Bonett, D. G. & Wright, T. A. Sample size requirements for estimating pearson, kendall and spearman correlations. Psychometrika 65, 23-28 (2000).
57. Bishara, A. J. & Hittner, J. B. Confidence intervals for correlations when data are not normal. Behav. Res. Methods 49, 294-309 (2017).